HAND1
Basic information
Region (hg38): 5:154474972-154478227
Links
Phenotypes
GenCC
Source:
- congenital heart disease (Moderate), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HAND1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 34 | 37 | ||||
missense | 72 | 77 | ||||
nonsense | 1 | |||||
start loss | 1 | |||||
frameshift | 1 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 6 | |||||
Total | 0 | 0 | 78 | 42 | 5 |
Variants in HAND1
This is a list of pathogenic ClinVar variants found in the HAND1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-154475807-C-T | Hypoplastic left heart syndrome | Uncertain significance (May 08, 2022) | ||
5-154475814-T-G | Hypoplastic left heart syndrome | Uncertain significance (Aug 17, 2023) | ||
5-154475839-C-A | Hypoplastic left heart syndrome | Likely benign (Oct 13, 2023) | ||
5-154475839-C-G | Hypoplastic left heart syndrome | Likely benign (Oct 04, 2023) | ||
5-154475845-G-C | Hypoplastic left heart syndrome | Likely benign (Nov 27, 2023) | ||
5-154475846-C-G | HAND1-related disorder • Hypoplastic left heart syndrome | Uncertain significance (Nov 07, 2023) | ||
5-154475848-G-A | Hypoplastic left heart syndrome | Likely benign (Oct 18, 2022) | ||
5-154475850-T-C | Hypoplastic left heart syndrome | Uncertain significance (Mar 22, 2022) | ||
5-154475854-T-C | Hypoplastic left heart syndrome | Likely benign (Aug 18, 2022) | ||
5-154475854-T-G | Hypoplastic left heart syndrome | Likely benign (Dec 03, 2021) | ||
5-154475867-T-C | Hypoplastic left heart syndrome | Uncertain significance (Nov 14, 2022) | ||
5-154475873-A-G | not specified | Uncertain significance (Jan 07, 2022) | ||
5-154475875-T-G | Hypoplastic left heart syndrome | Likely benign (Apr 11, 2023) | ||
5-154475880-C-T | Hypoplastic left heart syndrome | Uncertain significance (Oct 12, 2021) | ||
5-154475888-G-A | Hypoplastic left heart syndrome | Uncertain significance (Nov 08, 2023) | ||
5-154475889-G-A | Hypoplastic left heart syndrome | Uncertain significance (Feb 06, 2022) | ||
5-154475890-A-G | Hypoplastic left heart syndrome | Likely benign (Jul 07, 2023) | ||
5-154475892-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
5-154475903-T-A | Hypoplastic left heart syndrome | Uncertain significance (Jul 19, 2022) | ||
5-154475903-T-C | not specified | Uncertain significance (Oct 10, 2023) | ||
5-154475923-A-C | Hypoplastic left heart syndrome | Likely benign (Mar 22, 2023) | ||
5-154475928-G-C | Hypoplastic left heart syndrome | Likely benign (Nov 27, 2023) | ||
5-154477396-T-C | Benign (May 26, 2021) | |||
5-154477414-C-G | Benign (May 12, 2021) | |||
5-154477447-T-A | Hypoplastic left heart syndrome | Likely benign (Jan 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HAND1 | protein_coding | protein_coding | ENST00000231121 | 2 | 3293 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.109 | 0.786 | 125691 | 0 | 3 | 125694 | 0.0000119 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.284 | 133 | 124 | 1.07 | 0.00000587 | 1377 |
Missense in Polyphen | 34 | 36.396 | 0.93416 | 428 | ||
Synonymous | -1.18 | 64 | 53.1 | 1.21 | 0.00000271 | 449 |
Loss of Function | 1.27 | 2 | 5.09 | 0.393 | 2.19e-7 | 66 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000904 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor that plays an essential role in both trophoblast-giant cells differentiation and in cardiac morphogenesis. In the adult, could be required for ongoing expression of cardiac-specific genes. Binds the DNA sequence 5'- NRTCTG-3' (non-canonical E-box) (By similarity). {ECO:0000250}.;
- Pathway
- Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Heart Development;Neural Crest Differentiation;Mesodermal Commitment Pathway;nfat and hypertrophy of the heart
(Consensus)
Recessive Scores
- pRec
- 0.230
Intolerance Scores
- loftool
- 0.216
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.64
Haploinsufficiency Scores
- pHI
- 0.325
- hipred
- Y
- hipred_score
- 0.516
- ghis
- 0.458
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.994
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hand1
- Phenotype
- respiratory system phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;angiogenesis;mesoderm formation;blastocyst development;trophectodermal cell differentiation;heart looping;embryonic heart tube formation;cardiac left ventricle formation;cardiac right ventricle formation;transcription by RNA polymerase II;heart development;embryonic heart tube development;odontogenesis of dentin-containing tooth;negative regulation of DNA-binding transcription factor activity;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;ventricular cardiac muscle tissue morphogenesis;cardiac septum morphogenesis;mesenchyme development;cartilage morphogenesis;trophoblast giant cell differentiation;negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm;RNA polymerase II transcription factor complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;transcription coactivator activity;protein binding;transcription factor binding;enzyme binding;identical protein binding;protein homodimerization activity;bHLH transcription factor binding;transcription regulatory region DNA binding;protein heterodimerization activity